Alfredo Pauciulo

Dr. Alfredo Pauciulo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
MCManuel Cappellari
Manuel Cappellari
GPGiovanni Pracucci
Giovanni Pracucci
VSValentina Saia
Valentina Saia
EFEnrico Fainardi
Enrico Fainardi
ICIlaria Casetta
Ilaria Casetta
OGon behalf of the IRETAS group
on behalf of the IRETAS group

9 June 2025 in Interventional Neuroradiology
Verified
Journal Article
Open access
ECElisa Francesca Maria Ciceri
Elisa Francesca Maria Ciceri
ELEmilio Lozupone
Emilio Lozupone
MMMatteo Milani
Matteo Milani
MPMariangela Piano
Mariangela Piano
VCValentina Caldiera
Valentina Caldiera
CRChiara Riccietti
Chiara Riccietti
Background: The introduction of flow diverters (FDs) has revolutionized the treatment of complex intracranial aneurysms; subsequent surface modifications have extended their indications to ruptured, bifurcation, and distal aneurysms. The aim of this study is to assess the real-world feasibility and safety of HPC surface-modified devices in the treatment of ruptured and unruptured aneurysms. Methods: This independent, multicenter, prospective observational study evaluated the outcomes of patients treated with implanted Phenox p64 or p48 MW-HPC-FDs between 2020 and 2022. The sub-analysis of the procedures, complications (clinical and technical), and additional treatment requirements assessed the devices’ feasibility and safety in the peri-procedural period. Results: One hundred and forty aneurysms (35% ruptured and 65% unruptured) were treated in 140 patients (37 females and 103 males) using 153 HPC-FDs (111 p64 and 42 p48): 100 aneurysms were saccular (71%), 22 dissecting (16%), 13 fusiform (9%), and five blister-like (3.6%). The successful deployment rate was 97.9%. The overall peri-procedural mortality rate was 9%, including three device-related deaths (2.2%); the overall morbidity rate was 12.1% (6.4% severe, 3.6% mild, and 2.1% asymptomatic adverse events); 4.4% of the clinical adverse events were certainly device related, and 2.2% were probably device related. Conclusions: The use of p64 and p48 HPC-FDs is highly feasible and acceptably safe, although further data are needed to assess the impact of the coating on safety in emergency and elective procedures.

18 December 2025 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
ELEmilio Lozupone
Emilio Lozupone
RBRoland Barbante
Roland Barbante
GBGiovanni Barchetti
Giovanni Barchetti
MIMikel Terceño Izaga
Mikel Terceño Izaga
VVVictor Vazquez-Añón
Victor Vazquez-Añón
APAdriana Paladini
Adriana Paladini

1 June 2023 in Current Medical Imaging
Verified
Journal Article
Closed access
PDF file
GBGaetano Barbagallo
Gaetano Barbagallo
MCMarcella Caggiula
Marcella Caggiula
ARAnnalisa Rizzo
Annalisa Rizzo
VDVita Direnzo
Vita Direnzo
ALAngela Lupo
Angela Lupo
LBLeonardo Barbarini
Leonardo Barbarini
Background: Internuclear ophthalmoplegia (INO) is a disorder of eye movements caused by a lesion involving the medial longitudinal fasciculus (MLF) within the brainstem, and it is characterized by adduction impairment combined with contralateral dissociated abduction nystagmus. The frequency of acute ischemic stroke (AIS) presenting with INO as a predominant symptom is very low, and many patients suffering from this brainstem AIS are precluded from intravenous thrombolysis (IVT). Objective: To provide for the first time a magnetic resonance imaging (MRI) evidence of response to the IVT in brainstem wake-up stroke presenting with INO as an isolated symptom. Methods: Here, we described a rare case of pons AIS presenting with INO as a unique symptom of awakening. In order to differentiate an ischemic stroke from other stroke mimics, and to determine whether the patient was within the therapeutic window for IVT (wake-up stroke), brain MRI including DWI and FLAIR sequences was acquired. Results: A left paramedian pontine DWI/FLAIR mismatch was detected and the patient was considered eligible for IVT. After IVT, the patient made a full recovery with complete resolution of INO. Follow-up MRI at 1 month demonstrates the absence of ischemic lesions. Conclusion: Our case provides neuroradiological evidence of IVT efficacy in brainstem stroke, and it should prompt clinicians to rapidly perform MRI in wake-up onset INO and to just as quickly administer IVT, since INO is a functionally disabling deficit. Finally, this case demonstrates the value of MRI in diagnostic, prognostic, and therapeutic workup of posterior circulation wake-up stroke.

30 July 2026 in Neuroradiology
Verified
Journal Article
Open access
PDF file
AAAbdallah Aburub
Abdallah Aburub
Hans HenkesHans Henkes
Hans Henkes
AKAndré Kemmling
André Kemmling
MFMichael Forsting
Michael Forsting
ELEmilio Lozupone
Emilio Lozupone
AKAli Khanafer
Ali Khanafer
Background: Intracranial artery dissection (IADS) is an uncommon cause of acute ischemic stroke (AIS). In hyperacute settings, stenting is constrained by the need for intensive antiplatelet therapy. This study evaluated the antithrombogenic hydrophilic polymer–coated pEGASUS-HPC self-expanding stent for IADS-related AIS. Methods: This multicenter retrospective cohort study across seven stroke centers included consecutive patients with AIS and occlusion or severe flow-limiting stenosis caused by symptomatic IADS, who were treated with the pEGASUS-HPC. The outcomes were technical and angiographic success (device opening; mTICI score ≥2b when reperfusion was targeted), peri-procedural complications, mRS score, and follow-up patency. Results: In 36 treated patients (mean age 62.0 ± 19.6 years; 63.9% men), 91.7% of the dissections were spontaneous, and 80.6% were occlusive. Mechanical thrombectomy preceded stenting in 26/29 occlusive cases. Full stent opening occurred in 94.4%, and 100% reperfusion success was achieved in targeted vessels. Most patients received periprocedural intravenous antiplatelet bridging (75.0%) and were discharged on DAPT (77.8%). Whereas no intraprocedural complications occurred, four postprocedural events occurred during admission (11.1%), of which two were clinically significant and two were minor and asymptomatic. The mean NIHSS score improved from 11.8 at admission to 4.9 at discharge, and the mean discharge mRS score was 2.1. Clinical follow-up (mRS) was available in 33/36 patients (91.7%), with favorable functional outcome (mRS 0–2) in 27/33 (81.8%). Imaging follow-up at the early window (mean 94 days) was available in 27/36 (75.0%). In-stent stenosis ≥ 50% occurred in 14.8% and 4.2% of patients at early and mid-term follow-up, respectively, whereas no device occlusions or recurrent strokes occurred through mid-term follow-up. Long-term imaging follow-up (15/36, 41.7%) showed no new in-stent stenosis. Conclusions: pEGASUS-HPC stenting for IADS-related AIS was technically feasible and achieved high reperfusion rates and a low overall complication burden, thus supporting prospective evaluation with standardized antiplatelet protocols.

12 July 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Sara InvittoSara Invitto
Sara Invitto
PBPaolo Boscolo-Rizzo
Paolo Boscolo-Rizzo
GSGiacomo Spinato
Giacomo Spinato
GTGiuseppe Trinchera
Giuseppe Trinchera
GAGiuseppe Accogli
Giuseppe Accogli
Marina De TommasoMarina De Tommaso
Marina De Tommaso
Mild cognitive impairment (MCI) is a significant concern as it is a risk factor for AD progression, and early detection is vital in order to delay dementia onset and enable potential therapeutic interventions. Olfactory impairment is recognized as a predictive biomarker in neurodegenerative processes. The aims of this study were to explore the degree of entorhinal cortical atrophy (ERICA) and the severity of MCI symptoms; to analyze magnetic resonance imaging (MRI) results for the entorhinal cortex, parahippocampal gyrus, peri entorhinal cortex, and the cerebellar tentorium; and to perform a comprehensive neuropsychological and psychophysical assessment. The main results highlighted that in our sample—multidomain amnesic MCI patients with hyposmic symptomatology—we found that ERICA scores were associated with the severity of anxiety symptomatology. One possible hypothesis to explain this observation is that anxiety may contribute to neurodegenerative processes by inducing chronic stress and inflammation. Future research should consider the longitudinal development of neuropsychological scores, anxiety disorders, and brain atrophy to determine their potential predictive value for MCI progression. These findings suggest the importance of psychological factors in MCI progression and the utility of neuropsychological assessment alongside neuroimaging techniques for early detection and follow-up in MCI patients.